Drug-coated balloon versus drug‑eluting stent to reopen chronically blocked coronary arteries
Official title: Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion
Run by Biruni University · NCT07369765 · Data updated 2026-11-12
This trial will try drug‑coated balloons versus drug‑eluting stents in adults having PCI for chronic total occlusion to see which gives better vessel opening and fewer repeat procedures.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Biruni University Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | August 28, 2025 |
| Main results expected | August 1, 2026 |
| Study ends | August 1, 2027 |
| Registry record updated | January 27, 2026 |
| Trial ID | NCT07369765 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a single CTO suitable for PCI — specifically lesions 20–40 mm long in vessels ≥2.5 mm with successful intraplaque wiring and a high projected chance of procedural success — are ideal candidates.
✕Probably not a fit
Patients with multiple CTOs, in‑stent CTOs, severe lesion calcification, recent acute coronary syndrome, severe kidney failure, or life expectancy under one year are unlikely to benefit from inclusion.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional trial compares outcomes after percutaneous coronary intervention using drug‑coated balloon (DCB) angioplasty versus drug‑eluting stent (DES) implantation in adults with chronic total occlusion (CTO). Participants must meet predefined anatomical and procedural criteria, including CTO length 20–40 mm, vessel diameter ≥2.5 mm, and successful intraplaque wiring with TIMI flow ≥2 after predilation. Patients will be assigned to DCB or DES and followed for procedural success, angiographic patency, clinical events, and need for repeat revascularization. The trial is conducted at Biruni University in Istanbul and targets patients with a high likelihood of PCI success.
Why it matters
Potential benefit: If successful, DCB treatment could open the blocked artery without leaving a permanent metal stent, potentially lowering late complications and making future procedures easier.
How similar studies have gone: Smaller studies and registries of DCBs in selected coronary lesions have shown promising results, but strong randomized evidence specifically for CTOs is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Definite or probable CTO as per CTO-ARC definition * CTO length ≥ 20 mm and ≤ 40 mm; * High likelihood (≥90 %) of CTO-PCI success (balance between CTO lesion complexity and operator expertise); * Successful treatment of any non-CTO lesions at least 1 month before randomization; * CTO lesion location in a vessel segment with diameter ≥ 2.5 mm; * Successful intraplaque (intraluminal) wiring (extraplaque tracking \< 10 mm or \< 50% of occlusion length) with no flow-limiting dissection and a TIMI flow ≥ 2 after initial predilation with NC balloon. Exclusion Criteria: * Life expectancy \< 1 year as result of non-cardiac conditions; * Multiple CTO lesions that require recanalization; * Target lesion is an in-stent CTO; * Angiographic grade 3 calcifications in the CTO segment (Appendix 2); * Recent acute coronary syndrome (\< 1 month); * Cardiogenic shock or inability to stay in supine position for long time; * Severe kidney failure (eGFR ≤ 30 mL/min); * Any planned non-CTO PCI \< 12 months after randomization; * Anticipated less compliance of the patients to complete the following or taking medical therapy; * Patient or legal representative unable or unwilling to provide written informed consent prior to study enrollment; * Pregnancy or childbearing age unless a recent pregnancy test is negative.
Where it's running
-
Biruni University
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Sevket Gorgulu, MD
- Email: sevket5@yahoo.com
- Phone: +905059383527
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.